Response to The Wall Street Journal story
on the FBS (Symptom Validity) Scale
Pearson and the University of Minnesota Press are aware of an article about the FBS (Symptom Validity) Scale that appeared in The Wall Street Journal on March 5, in which items of the FBS (Symptom Validity) Scale were reproduced in the story and in a link to the newspaper’s website. Since then, we have been able to have the link showing FBS (Symptom Validity) Scale items removed from the newspaper’s website and are currently evaluating the impact of the article.
|
If you are a clinical professional and aware of other places where the FBS (Symptom Validity) Scale has been illegally reproduced, either in publications, websites,
chat rooms, or blogs, please:
Click here to send us an email with the details.
|
To Reach a Client Relations Representative | |
Call: 1-800-627-7271 7 AM-6 PM CST
Fax: 1-800-632-9011 or 952-681-3299
E-Mail: pearsonassessments@pearson.com |
|